GHDXUnknown
GENOMIC HEALTH INC Insider Trading Activity
Every SEC Form 4 insider transaction reported for GENOMIC HEALTH INC (GHDX), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are GHDX insiders buying or selling?
GENOMIC HEALTH INC insiders reported 1 open-market buys ($0) and 121 sells ($454.6M) across 122 Form 4 filings — a net selling position of $454.6M.
Source: SEC EDGAR Form 4
Key Statistics (as of Nov 13, 2019)
Total Form 4 filings
122
SEC EDGAR
Insider filers
12
Insider buys (1)
$0
Insider sells (121)
$454.6M
Insider sentiment
Net sellingNet insider flow of $454.6M in net selling.
Recent GHDX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 13, 2019 | EXACT SCIENCES CORP | Other, 10% Owner | Purchase | 37.6M | $0.00 | $0 |
| Oct 21, 2019 | Laura Leber | Chief Communication Officer | Sale | 13.2K | $70.94 | $935.2K |
| Oct 9, 2019 | James J Vaughn | Chief Commercial Officer | Sale | 4.5K | $67.75 | $304.9K |
| Oct 9, 2019 | Kimberly J Popovits | President and CEO | Sale | 10.0K | $67.74 | $677.4K |
| Oct 9, 2019 | Bradley G Cole | CFO | Sale | 22.6K | $69.01 | $1.6M |
| Sep 19, 2019 | Steven Shak | Chief Scientific Officer | Sale | 25.0K | $71.47 | $1.8M |
| Sep 11, 2019 | Kimberly J Popovits | President and CEO | Sale | 10.0K | $72.53 | $725.3K |
| Sep 11, 2019 | Bradley G Cole | CFO | Sale | 43.1K | $72.22 | $3.1M |
| Sep 11, 2019 | James J Vaughn | Chief Commercial Officer | Sale | 4.5K | $72.50 | $326.3K |
| Aug 21, 2019 | Frederic Pla | COO | Sale | 1.3K | $75.00 | $93.8K |
| Aug 19, 2019 | Jason W. Radford | Chief Legal Officer | Sale | 2.2K | $74.13 | $161.7K |
| Aug 19, 2019 | Jason W. Radford | Chief Legal Officer | Sale | 3.5K | $83.16 | $291.7K |
| Aug 14, 2019 | Bradley G Cole | CFO | Sale | 60.0K | $73.31 | $4.4M |
| Aug 14, 2019 | Kimberly J Popovits | President and CEO | Sale | 50.0K | $73.76 | $3.7M |
| Aug 12, 2019 | Kimberly J Popovits | President and CEO | Sale | 50.0K | $73.76 | $3.7M |
| Aug 12, 2019 | James J Vaughn | Chief Commercial Officer | Sale | 4.5K | $73.74 | $331.8K |
| Aug 7, 2019 | Kim Mceachron | Chief People Officer | Sale | 12.1K | $71.53 | $865.7K |
| Aug 7, 2019 | Steven Shak | Chief Scientific Officer | Sale | 50.0K | $71.83 | $3.6M |
| Aug 5, 2019 | Steven Shak | Chief Scientific Officer | Sale | 50.0K | $72.65 | $3.6M |
| Jul 11, 2019 | Bradley G Cole | CFO | Sale | 6.5K | $57.08 | $369.4K |
| Jul 10, 2019 | Steven Shak | Chief Scientific Officer | Sale | 50.0K | $56.81 | $2.8M |
| Jul 9, 2019 | James J Vaughn | Chief Commercial Officer | Sale | 4.5K | $57.09 | $256.9K |
| Jul 9, 2019 | Kim Mceachron | Chief People Officer | Sale | 5.3K | $60.01 | $320.2K |
| Jun 17, 2019 | Steven Shak | Chief Scientific Officer | Sale | 35.5K | $51.86 | $1.8M |
| Jun 13, 2019 | Steven Shak | Chief Scientific Officer | Sale | 50.0K | $51.38 | $2.6M |
Showing the 25 most recent of 122 Form 4 filings for GENOMIC HEALTH INC.
Most active GHDX insiders
- BAKER BROS. ADVISORS LP34 filings
- Steven Shak20 filings
- Bradley G Cole15 filings
- James J Vaughn15 filings
- Kimberly J Popovits15 filings
Ask anything about GHDX insider activity
Use Trabud's AI agent to query GENOMIC HEALTH INC's Form 4 history in plain English — "Show me GHDX CEO purchases this year" or compare it against any other ticker.
Open the AI agentGHDX insider trading FAQ
Are GENOMIC HEALTH INC insiders buying or selling?
Across 122 SEC Form 4 filings, GENOMIC HEALTH INC (GHDX) insiders reported 1 open-market purchases totaling $0 and 121 sales totaling $454.6M. That is a net selling position of $454.6M.
How many insiders trade GHDX stock?
12 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for GENOMIC HEALTH INC. The most recent filing was accepted on Nov 13, 2019.
Where does Trabud get GHDX insider trading data?
All GHDX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.